News
Press ReleaseCell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024
£86 million funding announced for new medicine and technologyRegulatory news - June 2017Designing a cell and gene therapy GMP cleanroomPress release: Cell Medica acquisition of WT1 T-cell therapyConstructing the Cell and Gene Therapy Catapult manufacturing centrePress release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Regulatory news - May 2017Gene-modified T-cells: Going into battleHighlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?ReNeuron awarded major UK cell therapy manufacturing grant